HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequency of loss expression of the DPC4 protein in various locations of biliary tract carcinoma.

AbstractOBJECTIVE:
To clarify the relationship between the loss of expression of the deleted in pancreatic carcinoma locus 4 (DPC4) proteins and the pathogenesis of biliary tract carcinoma.
METHODS:
71 primary biliary tract carcinoma (BTCa), including 38 common bile duct (CBD) carcinomas, 18 gallbladder carcinomas, 15 hilar bile ducts (HBD) carcinomas were examined by immunohistochemical staining. In addition, the CBD carcinomas were divided into two groups: tumors with metastasis (M(+) group, 27 cases) and tumors without metastasis (M(-) group, 11 cases).
RESULTS:
The frequency of loss of the expression of DPC4 protein was 32.8% in BTCa, 47.3% in CBD carcinoma, 11% in gallbladder carcinoma, 13% in HBD carcinoma. Comparison of the frequency of loss expression of DPC4 was significant statistical difference in CBD carcinoma versus gallbladder carcinoma and HBD carcinoma (P < 0.01). The frequency of loss expression of DPC4 was 48.1% in the M(+) group and 45.4% in the M(-) group.
CONCLUSION:
There are a close relationship between pathogenesis of BTCa and inactivation of DPC4 and different frequencies of DPC4 gene alternation in various locations of the biliary tract, which are not significantly increased with tumor metastasis in BTCa.
AuthorsZhaohui Tang, Shengquan Zou, Youhua Hao, Baoju Wang, Xiangping Yang, Fazu Qiu
JournalZhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] (Zhonghua Yu Fang Yi Xue Za Zhi) Vol. 36 Issue 7 Pg. 481-4 (Dec 2002) ISSN: 0253-9624 [Print] China
PMID12411149 (Publication Type: Journal Article)
Chemical References
  • DNA-Binding Proteins
  • Smad4 Protein
  • Trans-Activators
Topics
  • Bile Duct Neoplasms
  • Biliary Tract
  • Carcinoma
  • DNA-Binding Proteins (metabolism)
  • Humans
  • Pancreatic Neoplasms
  • Smad4 Protein
  • Trans-Activators

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: